# Transcranial Magnetic Stimulation + Language Therapy to Treat Subacute Aphasia

> **NCT06968663** · PHASE2 · RECRUITING · sponsor: **University of Pennsylvania** · enrollment: 63 (estimated)

## Conditions studied

- Stroke
- Aphasia
- Aphasia Following Cerebral Infarction

## Interventions

- **DEVICE:** Transcranial Magnetic Stimulation (TMS)
- **BEHAVIORAL:** Modified Constraint Induced Language Therapy (mCILT)

## Key facts

- **NCT ID:** NCT06968663
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-08
- **Primary completion:** 2029-07-31
- **Final completion:** 2029-07-31
- **Target enrollment:** 63 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06968663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06968663, "Transcranial Magnetic Stimulation + Language Therapy to Treat Subacute Aphasia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06968663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*